Johnny Isakson actually said...
We don't want to, in any way, legislate what FDA should approve. But we want to get a more transparent and a more effective system of evaluating these important ingredients for this terrible cancer.
Context
Isakson emphasizes the need for transparency in FDA evaluations for skin care ingredients.
03/12/2014